RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$205.15
+7.34 (+3.71%)
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Price Target
Analyst Price Target
-44.4% upside
Low Target
$80.83
Average Target
$114.11
High Target
$120.13
Current Price
$205.15
Current
$205.15
$205.15
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Scenario Analysis
Bear Case
$80.83
-60.6%
Low target
Base Case
$114.11
-44.4%
Avg target
Bull Case
$120.13
+-41.4%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$203.00
1.1% from high
52-Week Low
$34.00
+503.4% from low
50-Day SMA
$94.85
+116.3% vs SMA
200-Day SMA
$58.23
+252.3% vs SMA
RSI (14)
62.5
Neutral
Target vs 52W High
$114.11
-43.8% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
3d
until earnings
EPS Est: $-2.02
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |